Bank of America’s Adverum Biotechnologies ADVM Stock Holding History

Bank of America’s Portfolio ADVM Stock Details ADVM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-7,000	Closed	-$806K	–	6798
2019 Q4	$806K	Sell	7,000 -2,000	-22%	-$176K	﹤0.01%	4646
2019 Q3	$491K	Buy	+9,000	New	+$1.01M	﹤0.01%	5098
2016 Q1	–	Sell	-8,000	Closed	-$762K	–	6955
2015 Q4	$762K	Buy	+8,000	New	+$703K	﹤0.01%	4542

Bank of America's ADVM Position: Q4 2025 in Review

Bank of America sold out of Adverum Biotechnologies (ADVM) in Q4 2025, closing a stake of 3,614 shares — an estimated $16.4K sold.

Bank of America first reported a position in ADVM in Q4 2014 and held it in 42 quarters. The position peaked at $8.89M in Q2 2023. 0 funds tracked by Wall St. Rank hold ADVM as of Q4 2025.

Bank of America reported no remaining Adverum Biotechnologies position as of Q4 2025 after selling out during the quarter.
Bank of America sold 3,614 Adverum Biotechnologies shares in Q4 2025, an estimated $16.4K.
Bank of America first reported a position in Adverum Biotechnologies in Q4 2014 and held it in 42 quarters.
Bank of America's Adverum Biotechnologies position peaked at $8.89M in Q2 2023.
0 funds tracked by Wall St. Rank held Adverum Biotechnologies as of Q4 2025.

Based on Bank of America's 13F filing for Q4 2025, filed 17 Feb 2026.